baber/WOPTO huggingface dataset:
Patent AT-E261016-T1 (AT)
Inventor: WESTERKAMP ARVED H
IPC: D21F1/10
Filed: 1999-12-04
Granted: 2004-03-15
Abstract: The compound woven fourdrinier, for the wet section of a papermaking machine, is in three or more layers. An additional weft layer (50) is woven into the structure between the weft layer (44) of at least one upper woven material (42) and the weft layer (46) of at least one lower woven material (43). The upper and lower weft layers (44,46) are separated by the additional weft layer (50). The filaments (2,6,10...34,38) of the additional weft group (50) alternate with the bonding filaments (4,8,12...36,40) woven into at least one upper (42) and at least one lower (43) material. All the warps (45) of the upper woven material (42) lie over the additional weft group (50), and all the warps of the lower woven material (42) are under it. All the wefts (44,46,50) lie on a common and generally vertical plane. The wefts of the additional weft group (50) are offset vertically from the wefts (44,46) of at least one upper (42) and at least one lower (43) woven material.
Patent AT-E318327-T1 (AT)
Inventor: WITTWER CARL T
IPC: C12N15/09
Filed: 1997-06-04
Granted: 2006-03-15
Abstract: A method for detecting a target nucleic acid sequence in a biological sample during amplification comprising adding a thermostable polymerase and primers configured for amplification of the target nucleic acid to the biological sample, amplifying the target nucleic acid sequence by PCR in the presence of a heat labile double-strand specific dye, conducting the PCR through a number of amplification cycles, illuminating the biological sample comprising the amplified target nucleic acid sequence with light at a wavelength absorbed by the dye, and detecting a fluorescent emission from the dye related to the quantity of the amplified target nucleic acid sequence in the sample.
Patent AT-E301481-T1 (AT)
Inventor: SCHMITZ-RODE THOMAS
IPC: F04D29/18
Filed: 1999-01-20
Granted: 2005-08-15
Abstract: The axial-flow pump for introduction through the vascular system of a patient has a flexible compressible tube (1) forming the pump housing. A radially compressible rotor (7) is located within the tube (1). The drive shaft (6) of the rotor (7) extends through a catheter (4). The catheter (4) can be pulled into a cover hose (5) together with the tube (1) and the rotor (7).
Patent AT-E328900-T1 (AT)
Inventor: ANGEL PETER
IPC: G01N33/15
Filed: 1999-03-18
Granted: 2006-06-15
Abstract: The invention relates to transcription factors with a DNA binding domain consisting of a basic domain and an adjacent leucine zipper domain. The aim of the invention is to provide modified transcription factors whose binding behaviour towards each other and towards DNA sequences can be manipulated. To this end, at least one amino acid on the leucine zipper is replaced by a loaded amino acid.
Patent AT-E235156-T1 (AT)
Inventor: BLUMENBERG KLAUS-DIETER
IPC: A22C13/00
Filed: 1999-04-16
Granted: 2003-04-15
Abstract: Process for producing dyed, tubular food wrappings from non-woven fabric coated with regenerated cellulose, characterized in that an alkaline dye liquor containing at least one dye which has been previously converted into an alkali-soluble form by chemical reduction and which can be converted into its insoluble form by oxidation is admixed to the viscose solution used for the production of the layer of regenerated cellulose, a tubular non-woven fabric is coated with the mixture of viscose solution and dye liquor, the viscose is coagulated and regenerated to form cellulose hydrate gel and the dye distributed in the viscose is reconverted into its insoluble form by oxidation; tubular food wrappings produced by this process and their use as synthetic casings for sausages.
Patent AT-E253061-T1 (AT)
Inventor: LABRECQUE DENIS
IPC: C07D307/68
Filed: 1999-06-29
Granted: 2003-11-15
Abstract: A novel compound which inhibits certain integrins, particularly alpha<SUB>v </SUB>integrins. Additionally, the novel compound may be used in a method of treating tumors or cancer which comprises administering a pharmaceutically effective amount of the compound to a patient. Additionally, the novel compound may be used in a method of inhibiting angiogensis. Finally, a method of producing the novel compound is disclosed.
Patent AT-E274878-T1 (AT)
Inventor: KOCH RUDOLF
IPC: A61F2/00
Filed: 1999-11-03
Granted: 2004-09-15
Abstract: A hip-joint socket having an outer shell (1) with a central axis (7) that is to be anchored in the hip bone. The outer shell is detachably mounted, in a geometrically locking manner, on a plastic intermediate shell (1a) exhibiting a hollow-spherical inner side (2). The hip-joint socket also has a wear-resistant inner shell (3) with a spherical outer side (4) and a central axis (8) that is designed to receive a joint ball of a femur shaft. The outer side (4) of the inner shell (3) can be undetachably mounted in a geometrically locking manner to rest against the inner side (2) of the intermediate shell (1a) such that the two central axes (7, 8) coincide. Mutually engaging elements are present at the inner shell and intermediate shell (3 resp. 1a) that consist, on one hand, of a prismatic salient (5) configured at the vertex (9) of the inner shell (10) on the outer side (4) and, on the other hand, of a prismatic recess (6) configured at the vertex (10) of the intermediate shell (1a) on the inner side (2). The salient and recess reliably preclude the mutually contacting inner and intermediate shells (3 resp. 1a) from rotating about their central axes (7, 8) and from canting relative to each other. The salient (5) and the recess (6) are configured in substantially congruent and symmetrical manner relative to the central axes. The hip-joint socket offers minimal design height subjected to optimally distributed resting forces.
Patent AT-E380020-T1 (AT)
Inventor: KERC JANEZ
IPC: A61K9/20
Filed: 1999-10-29
Granted: 2007-12-15
Abstract: Lovastatin, pravastatin, simvastatin, mevastatin, atorvastatin, and derivatives and analogs thereof are known as HMG-CoA reductase inhibitors and are used as antihypercholesterolemic agents. The majority of them are produced by fermentation using microorganisms of different species identified as species belonging to Aspergillus, Monascus, Nocardia, Amycolatopsis, Mucor or Penicillium genus, and some are obtained by treating the fermentation product s using the methods of chemical synthesis or they are the products of total chemical synthesis.  The aforementioned active substance s may be destabilised by the environmental factors, their degradation may al so be accelerated by interactions with other pharmaceutical ingredients, such as fillers, binders, lubricants, glidants and disintegrating agents, therefore the pharmaceutical ingredients and the process for preparation of the pharmaceutical formulation should be meticulously chosen to avoid the aforementioned undesired interactions and reactions.  The present invention relates to a stable solid pharmaceutical formulation for the treatment of hypercholesterolemia and hyperlipidemia. More precisely, the present invention relates to the new stable solid pharmaceutical formulation containing as an active ingredient a HMG-CoA reductase inhibitor, such as atorvastatin, pravastatin, fluvastatin and cerivastatin or pharmaceutically acceptable salt s thereof.
Patent AT-E332537-T1 (AT)
Inventor: DOWLING JOHN H
IPC: G06K7/10
Filed: 1999-09-10
Granted: 2006-07-15
Abstract: A hand-held imager which is capable of reading both linear and two dimensional symbologies, which can perform focusing and illuminating steps quickly and accurately so as to eliminate variation in the position of the imager relative to the code becoming a negative factor, in which can operate in an environment where the imager is anywhere from 1.5 inches to 16 inches from the code. The imager includes an imaging system having a focusing system, an illumination system, and a two-dimensional photodetector which forms an image of the coded symbology. After achieving targeting of the coded symbology, the scanning system adjusts the focus between multiple different focuses, and utilizes a portion of the two-dimensional photodetector to determine the optimum focus. Upon the determination of optimum focus, the focusing system is returned to the focusing configuration established in the initial focusing step, and an image is created using the entire two-dimensional photodetector. Optimum illumination is determined using the same two-dimensional photodetector.
Patent AT-E401846-T1 (AT)
Inventor: GAUCHET FABIEN
IPC: A61B17/70
Filed: 1999-12-09
Granted: 2008-08-15
Abstract: An intervertebral disc prosthesis comprising two opposing plates and a flexible seal extending between the two opposing plates for forming a closed chamber between the two plates, the flexible seal being adapted to enable the plates to move relative to one another. The disc prosthesis also includes a compressible body disposed in the closed chamber and located between the plates. The compressible body has a first surface in contact with a face of one of the plates, whereby an area of contact between the first surface of the compressible body and the face of the one of the plates increases when compressive forces are exerted upon the compressible body.
Patent AT-E342966-T1 (AT)
Inventor: ANDERSEN VILBOUR KIM
IPC: C12N15/09
Filed: 1999-12-20
Granted: 2006-11-15
Abstract: Subtilase enzymes of the I-S1 and I-S2 sub-groups having an additional amino acid residue in position 95 of the active site loop (b) region from position 95 to 103. Variant subtilases exhibit improved wash performance in a detergent in comparison to its parent enzyme.
Patent AT-E246547-T1 (AT)
Inventor: NITOWSKI GARY A
IPC: B65D1/00
Filed: 1999-12-21
Granted: 2003-08-15
Abstract: Primer composition comprising aqueous solution containing vinylphosphonic acid-acrylic acid copolymer, is coated on aluminum oxide or aluminum hydroxide surface of an aluminum alloy sheet, to form a primer layer comprising reaction product of copolymer and aluminum oxide or hydroxide. The primer layer is coated with coating composition comprising polymer such as polyvinyl chloride, epoxies or polyester. INDEPENDENT CLAIM is also included for the following: (i) Polymer coated aluminum alloy sheet; and (ii) Aluminum alloy container body or end panel.
Patent DE-11826290-T1 (DE)
Title: Verfahren und systeme für kohärente bildgebung und rückkopplungssteuerung zum modifizieren von materialien
Inventor: WEBSTER PAUL J L
IPC: G05B19/401
Filed: 2011-09-26
Abstract: Vorrichtung, die Folgendes umfasst:eine Materialverarbeitungsstrahlquelle, die einen Materialverarbeitungsstrahl erzeugt, der an eine Probenstelle in einem Materialmodifizierungsprozess angelegt wird;eine optische Bildgabequelle, die Bildgabelicht erzeugt;ein optisches Interferometer, das ein Interferometrie-Ausgangssignal unter Verwendung mindestens einer Komponente des Bildgabelichts erzeugt, das auf die Probe gerichtet wird, wobei das Interferometrie-Ausgangssignal auf mindestens einer Länge eines optischen Pfades zu der Probe im Vergleich zu einer anderen Länge eines optischen Pfades basiert; undeinen Rückmeldungs-Controller, der mindestens einen Verarbeitungsparameter des Materialmodifizierungsprozesses auf der Basis des Interferometrie-Ausgangssignals steuert.
Patent ES-2172483-T1 (ES)
Inventor: LOTZ HORST K
IPC: B23C5/02
Filed: 2000-07-15
Abstract: Device for removing oxygen whiskers (2) from steel workpieces such as slabs, ingots and billets comprises a whisker-removing roller (1), a whisker-removing roller segment on its horizontal axle journal, or a whisker-removing plate on its vertical axle journal (5) which can be rotated using an electromotor or hydraulic drive. The casing of the roller or roller segment coils partially or completely with a circulating knife (4). The knife interacts at an angle of 10-80 degrees to the whiskers.
Patent ES-2201945-T1 (ES)
Inventor: DUPIELET NORBERT
IPC: E06B9/80
Filed: 2001-02-19
Abstract: The invention concerns a powered rolling shutter whereof the stator of the motor is connected to a fixed support via elastic means (R1, R2) for stopping the shutter in high and low abutment when the resisting torque exceeds a selected value, consisting of two springs (R1, R2) compressed by the stator rotation. The travel distance (12) before on of the springs (R2) is compressed is greater than the travel distance (11) before the other spring (R1) is compressed. The compression is ensured by a mobile element (12) also actuating a switch (18). The travels (c1, c2) required for activating the switch can be inverted. The motor can be mounted on the left or on the right with a differentiated resisting torque for stopping in high abutment and low abutment.
Patent ES-2042458-T1 (ES)
Inventor: VATTEMENT HUBERT
IPC: C09K17/02
Filed: 1992-12-04
Abstract: An injection grout for sealing and/or consolidating soils or materials exhibiting a very low permeability, of the type consisting of the mixture of a powder based on slag in suspension in water and of a silica liquor. The silica liquor has an SiO2/Na2O molar ratio lower than 0.8 and a silica content of between approximately 0.01 and 5 % by weight. The invention also relates to a process for its manufacture.
Patent ES-2056043-T1 (ES)
Inventor: BRAUN HEINRICH DIPL-ING
IPC: B23P15/00
Filed: 1993-09-24
Abstract: In order to provide a method for manufacturing welded sheet steel plates from individual sheet panels cut from steel strips suitable for the plate parts, which combines the advantages of the hitherto known methods with one another in a simple manner and avoids the disadvantages of these methods, sheet panels of several times the length of the sheet steel plates are divided off from the steel strips, welded to one another at their longitudinal edges, and subsequently the individual sheet steel plates are detached from the composite panels resulting from the sheet panels.
Patent ES-2065874-T1 (ES)
Title: Bolsa de gas inflable para un sistema de retencion en vehiculos.
Inventor: KRICKL RUDI
IPC: B60R21/16
Filed: 1994-04-20
Abstract: UN SACO (10) DE GAS INFLABLE PARA UN SISTEMA DE RESPALDO EN AUTOMOVILES ESTA CONFIGURADO TODO LO MAS A PARTIR DE DOS PARTES (14,16) TEXTILES DESARROLLABLES EN UN PLANO, CUYOS BORDES (18,20) ESTAN UNIDOS UNO CON OTRO POR MEDIO DE UNA COSTURA (28). A PARTIR DE ESTAS PARTES (14,16) TEXTILES SE OBTIENE UNA CONFORMACION GENERAL EN FORMA DE CUÑA O DE OTRA FORMA GENERAL DEL TIPO DE MARIPOSA.
Patent ES-2117606-T1 (ES)
Title: Instalacion para fijar una cubierta de bolsa de gas.
Inventor: FISCHER ANTON
IPC: B60R21/20
Filed: 1997-09-02
Abstract: DISPOSITIVO PARA FIJAR UNA CUBIERTA DE BOLSA GASEOSA (1) A UNA PIEZA DE VEHICULO, ESTANDO CONFORMADO EL DISPOSITIVO COMO UNION POSITIVA POR ENCASTRE ELASTICO, QUE ENCAJA EN UN ALMA DE FIJACION (7) AMOLDADA A LA CUBIERTA DE BOLSA GASEOSA (1), CARACTERIZADO PORQUE EN LA PIEZA DE VEHICULO SE HA ALOJADO UN ELEMENTO DE ENCLAVAMIENTO (11), QUE PUEDE MOVERSE MEDIANTE UN ELEMENTO ELASTICO (23) DE UNA POSICION BASICA A UNA DE ENCLAVAMIENTO, Y PORQUE SE HA PREVISTO UN MECANISMO DE ENCASTRE QUE IMPIDE QUE EL ELEMENTO ELASTICO (23) ACTIVE EN LA POSICION BASICA EL ELEMENTO DE ENCLAVAMIENTO (11) Y QUE PUEDE LIBERARSE APRETANDO LA CUBIERTA (1) DURANTE EL MONTAJE DE LA MISMA.
Patent ES-2130107-T1 (ES)
Inventor: GRESSIER CHRISTOPHE
IPC: B60P7/08
Filed: 1998-11-18
Abstract: The platform (1) is made from one or more hollow sections made from lightweight metal, preferably aluminum alloy, positioned lengthwise relative to the direction in which the vehicle moves. Each section comprises upper and lower skins and a lattice of inner vertical and oblique webs to make it self-supporting, and is shaped to receive clip-on components such as fastenings or flooring.
Patent CY-1108045-T1 (CY)
Inventor: CHEN YING-NAN PAN
IPC: A61P35/00
Filed: 2008-02-18
Abstract: A combination therapy for treating patients suffering from pre-malignant colon lesions (e.g. polyps) and colon cancer, as well as other malignancies, is disclosed. The patient is treated concurrently with a cycloocygenase-2 inhibitor and at least one compound selected from the group consisting of a microtubule interfering agent, an epithelial growth factor receptor tyrosine protein kinase inhibitor and a vascular endothelial growth factor receptor tyrosine kinase inhibitor.
Patent CY-1109139-T1 (CY)
Title: Συνδυασμοι που περιλαμβανουν αντιμουσκαρινικους παραγοντες και βητα-αδρενεργικους αγωνιστες
Inventor: GRAS ESCARDO JORDI
IPC: A61K31/573
Filed: 2009-06-09
Abstract: Ενας συνδυασμός που περιλαμβάνει (α) ένα β2 αγωνιστή και (β) ένα ανταγωνιστή των Μ3 μουσκαρινικών υποδοχέων ο οποίος είναι 3(R)-(2-hydroxy-2,2-dithien-2-ylacetoxy)-1-(3-phenoxypropyl)-1-azoniabi-cyclo [2.2.2]octane, στη μορφή ενός άλατος που έχει ένα ανιόν Χ, το οποίο είναι φαρμακευτικά αποδεκτό ανιόν ενός μονο ή πολυδύναμου οξέος.
Patent CY-1110237-T1 (CY)
Inventor: VERHAAR MARK THEODOOR
IPC: C07J1/00
Filed: 2010-07-20
Abstract: A process is provided for the making of estetrol starting from a 3-A-oxy-estra-1,3,5(10),15-tetraen-17-one, wherein A is an C1-C5 alkyl group, preferably a methyl group, or a C7-C12 benzylic group, preferably a benzyl group. This process is particularly suitable to industry.
Patent CY-1111000-T1 (CY)
Inventor: MANTEGAZZA GIOVANNI
IPC: D01F6/74
Filed: 2010-12-23
Abstract: The building component comprises a central structure covered by a layer of cement mortar in which a reinforcement structure formed of poly[benz(1,2-D:5,4-D')bisoxazole-2,6-diyl-1,4-phenylen] fibre is embedded. The method consists of forming a layer of cement mortar on the structure to be reinforced and embedding in the cement mortar layer a reinforcement structure formed of poly[benz (1,2-D:5,4-D')bisoxazole-2,6-diyl-1,4-phenylen] fibre. The mortar further comprises unsaturated copolymer resins, fluidifying and thixotropic additives.
Patent CY-1113176-T1 (CY)
Title: Παρασκευη ταξανων απο 9-διυδρο-13-ακετυλοβακκατινη iii
Inventor: CARON GAéTAN
IPC: C07D305/14
Filed: 2012-10-08
Abstract: Η παρούσα εφεύρεση αφορά νέα διαδικασία παρασκευής ενδιάμεσων προϊόντων της 9-διυδροβακκατίνης III, που χρησιμεύουν ως πρόδρομα μόρια για την παρασκευή της πακλιταξέλης, 1, δοσεταξέλης, 2, και αναλόγων αυτών. Ειδικότερα, η διαδικασία περιλαμβάνει τα βήματα (i) της ταυτόχρονης απακετυλίωσης εστέρων στη θέση 10 και 13 της 9-διυδρο-13-ακετυλοβακκατίνης III για το σχηματισμό 9-διυδρο-10-απακετυλοβακκατίνης III' (ii) της προστασίας κάποιας υδροξυ-ομάδας στη θέση 7 της 9-διυδρο-10-απακετυλοβακκατίνης III- και (iii) της ακυλίωσης κάποιας υδροξυ-ομάδας στη θέση 10 για το σχηματισμό του χημικού τύπου II.
Patent CY-1114753-T1 (CY)
Title: Παραγωγα αμινοθειαζολιου και οι χρησεις τους ως αντιβακτηριακοι παραγοντες
Inventor: LAMARCHE MATTHEW J
IPC: C07K5/06
Filed: 2014-01-09
Abstract: Η παρούσα αίτηση περιγράφει οργανικές ενώσεις οι οποίες είναι χρήσιμες στη θεραπευτική αντιμετώπιση, πρόληψη και/ή βελτίωση νόσων.
Patent CY-1117641-T1 (CY)
Title: Αναστολεις του ιου της ηπατιτιδας c
Inventor: BACHAND CAROL
IPC: C07D403/14
Filed: 2016-06-15
Abstract: Η παρούσα αποκάλυψη σχετίζεται με μια ένωση του Χημικού Τύπου (I), με συνθέσεις και μεθόδους για την αγωγή της λοίμωξης από τον ιό της ηπατίτιδας C (HCV). Επίσης αποκαλύπτονται και θεραπευτικές συνθέσεις που περιέχουν τέτοιες ενώσεις και μέθοδοι για χρήση αυτών των ενώσεων στην αγωγή της λοίμωξης από τον HCV.
Patent CY-1118271-T1 (CY)
Title: Προϊοντα γονιδιων εκφραζομενα διαφορικα μεσα σε ογκους και εφαρμογη αυτων
Inventor: Türeci Özlem
IPC: C07K16/30
Filed: 2016-10-25
Abstract: Σύμφωνα με την εφεύρεση αναγνωρίζονται εκφραζόμενα προϊόντα γονιδίων που σχετίζονται με όγκο και τα νουκλεϊκά οξέα που τα κωδικοποιούν. Η παρούσα εφεύρεση αφορά στην θεραπεία και την διάγνωση ασθενειών, στις οποίες αυτά τα προϊόντα γονιδίων που σχετίζονται με όγκο εκφράζονται ανώμαλα. Περαιτέρω η εφεύρεση αφορά σε πρωτεΐνες, πολυπεπτίδια και πεπτίδια που εκφράζονται σε συνδυασμό με όγκο και στα νουκλεϊκά οξέα που τα κωδικοποιούν.
Patent CY-1119223-T1 (CY)
Title: Μεθοδος παραγωγης καυσιμου για ενεργειακες εφαρμογες
Inventor: CUBER PETR
IPC: C10B47/46
Filed: 2017-06-27
Abstract: Δοχεία υπό πίεση (1), τα οποία περιλαμβάνουν φορτίο, προθερμαίνονται σε πίεση 2 έως 5 kPa με υγρό φορέα θερμότητας (8) μέχρι τους 120 °C το μέγιστο και, στη συνέχεια, υποβάλλονται σε αναθέρμανση σε άλλο σημείο, έως τους 550 °C το μέγιστο, ενώ προστίθενται και/ή αντικαθίστανται συνεχώς τα δοχεία υπό πίεση (1) και τα αέρια που παράγονται απομακρύνονται συνεχώς, ψύχονται σε θερμοκρασία 60 °C το μέγιστο και τα διαχωρισμένα αέρια υπολείμματα, το ελαιώδες συμπύκνωμα και τα στερεά υπολείμματα υποβάλλονται σε καύση μετά από επεξεργασία σε μονάδα συμπαραγωγής (20).Η συσκευή περιλαμβάνει μονάδα προθέρμανσης (2) και μονάδα αναθέρμανσης (3) με διασυνδεδεμένο υγρό φορέα θερμότητας (8) βάσεις (9) που περιλαμβάνουν δοχεία υπό πίεση (1) εξοπλισμένα με έξοδο (5) σε σωλήνωση αερίου (7). Κατά προτίμηση, στη σωλήνωση αερίου (7) συνδέονται ψύκτης (17) και δοχείο/δοχεία αερίου (19). Η σωλήνωση συμπυκνώματος (16) και η σωλήνωση αερίου (7) καταλήγουν στη μονάδα συμπαραγωγής (20) και, ανάλογα με την περίπτωση, ενδέχεται να υπάρχει εναλλάκτης θερμότητας (15) συνδεδεμένος στον υγρό φορέα θερμότητας (8).
Patent CY-1119843-T1 (CY)
Title: Φαινυλοξικη l-ορνιθινη και μεθοδοι παρασκευης αυτης
Inventor: ANDERSON KEITH
IPC: C07C229/26
Filed: 2017-12-20
Abstract: Αποκαλύπτονται στο παρόν κρυσταλλικές μορφές φαινυλοξικής L-ορνιθίνης και μέθοδοι παρασκευής αυτών. Η κρυσταλλική μορφή μπορεί, σε κάποιες υλοποιήσεις, να είναι οι Μορφές I, II, III και V ή μείγματα αυτών. Οι κρυσταλλικές μορφές μπορούν να μορφοποιηθούν για τη θεραπεία υποκειμένων με ηπατικές διαταραχές, όπως ηπατική εγκεφαλοπάθεια. Επομένως, κάποιες υλοποιήσεις περιλαμβάνουν σκευάσματα και μεθόδους χορήγησης της φαινυλοξικής L-ορνιθίνης.
Patent CY-1119753-T1 (CY)
Title: Λυσινικη αλφα αζτρεοναμη
Inventor: MONTGOMERY ALAN BRUCE
IPC: A61K31/427
Filed: 2017-12-28
Abstract: Η λυσινική α-αζτρεονάμη μπορεί να χορηγηθεί μέσω εισπνοής. Είναι χρήσιμη στη θεραπεία πλευμονικών βακτηριακών λοιμώξεων, ιδίως gram-αρνητικών βακτηριακών λοιμώξεων.
Patent CY-1123554-T1 (CY)
Title: Μικροσφαιριδια που περιεχουν αντιελμινθικες μακροκυκλικες λακτονες
Inventor: CORACE GIUSEPPE
IPC: A61K9/00
Filed: 2020-11-10
Abstract: Αποκαλύπτονται μικροσφαιρίδια που περιέχουν 1 έως 20% κατά βάρος μιλβεμυκίνη, αβερμεκτίνη ή ένα παράγωγο αυτών, 50% έως 95% κατά βάρος ένα λίπος, έναν κηρό ή ένα μείγμα αυτών, 0,1% έως 10% κατά βάρος ένα στεροειδές λιπίδιο, κατά προτίμηση χοληστερόλη και 0,01 έως 1% κατά βάρος ένα αντιοξειδωτικό.
Patent HR-P20110528-T1 (HR)
Title: Methods for synthesis of encoded libraries
Inventor: MORGAN BARRY
IPC: C07H21/00
Filed: 2011-07-13
Abstract: The present invention provides a method of synthesizing libraries of molecules which include an encoding oligonucleotides tag.
Patent SI-1335083-T1 (SI)
Title: Method for renovating power pylons consisting of steel lattices
Inventor: HENSCHEL WERNER DIPL-ING
IPC: E04H12/10
Filed: 2002-02-09
Abstract: The method involves fixing at least one tie rod (3) to the mast in its longitudinal direction, whereby one end of the tie rod is attached to one corner strut (1) and the other end is fixed to the base (2) or to a corner strut, whereby the tie rod is placed under tension. One tie rod can be mounted along a corner strut with its upper ad attached to the strut and the lower end to the base.
Patent SI-1628368-T1 (SI)
Title: Explosion-proof cable feedthrough
Inventor: DEVULDER JEAN-FRANCOIS
IPC: H01R13/00
Filed: 2005-07-26
Abstract: The feedthrough has an intermediate part (7) with threadings (8, 9) for a tubular body (4) and a cap (10) cooperating with threaded holes (6, 12) of the body and the cap, respectively. The cap screwed on the part (7) compresses a packing seal (11) and the hole (12). A part of an electrical connector (1) adjacent to a cable bundle (2) and a part of the bundle adjacent to the connector are coated with an epoxy resin mass.